Clinical Trials
16 trialsNCT02834013 2026-05-13
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT07170644 2026-05-08
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2 Active not recruiting
NCT07541430 2026-04-30
A Study in Adults With Desmoid Tumors
Elpiscience Biopharma, Ltd.
Phase 2 Recruiting
NCT04195399 2026-04-15
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Children's Oncology Group
Phase 2 Active not recruiting
NCT05949099 2025-09-08
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Stanford University
Phase 2 Recruiting
NCT01981551 2024-02-06
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03275818 2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Completed
NCT03966742 2022-03-25
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Rabin Medical Center
Phase 2 Completed
NCT00068419 2020-02-19
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
Phase 2 Completed
NCT01137916 2017-05-03
Study to Evaluate Imatinib in Desmoid Tumors
Heidelberg University
Phase 2 Completed
NCT00978146 2017-04-20
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
Children's Hospital of Philadelphia
Phase 2 Withdrawn
NCT00474994 2016-01-20
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02353429 2015-02-02
Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT00003019 2014-07-25
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Children's Oncology Group
Phase 2 Completed
NCT00030680 2013-08-27
Radiation Therapy in Treating Patients With Aggressive Fibromatoses
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00002595 2013-07-10
Toremifene in Treating Patients With Desmoid Tumors
National Cancer Institute (NCI)
Phase 2 Completed